average weight loss with glp-1 agonists Drugs Market Report, 2025-2030 November Blog - What happens

For weight loss, your clinician will likely look at your BMI (body mass index)a rough estimate of your body composition based on your height and weight

Some people experience no gastrointestinal issues with tirzepatide but cannot tolerate semaglutide, or vice versa

Navigate the healthcare industry Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed

Ji L, Jiang H, Cheng Z, et al

Its important to note that just four days ago, a paper in the American Journal of Ophthalmology found that there was no significant increase in risk of NAION or (ischemic optic neuropathy) in patients taking semaglutide or GLP-1 drugs compared to control group patients with Type 2 diabetes or high BMI